JSA / WAO joint Congress 2020

Call for Abstracts

Thank you for submitting your abstract to JSA/WAO Joint Congress 2020.
We have reviewed all submitted abstracts carefully and we are now pleased to announce the results.
We sent the notification on July 31, and please contact congress secretariat (abs_jsawac2020@c-linkage.co.jp) if you’ve not received the email.

(Last updated August 27, 2020)

Presentation styles and topics

Accepted abstracts will be presented in Oral Sessions or Poster Sessions.
All presentations must be in English.
Authors can indicate their choice of preferred type of presentation in our submission system.

To those who who reside in Japan:
In order to submit an abstract as a first author/presenter, you must be a member of the Japanese Society of Allergology（JSA) and you are requested to enter your JSA Member ID to complete your submission. If you are a Non-JSA member or applying to become a member, please enter "99" to continue.
日本語での演題投稿を希望する方はこちら。UMINシステムにて募集いたします。

Please understand that the final decisions regarding the allocation and the type of presentation of the submitted abstracts will be made by the Joint Congress Scientific Program Committee.

The scientific program committee seeks abstracts in the following topics.
Authors will be asked to select 2 topics when submitting their abstract(s).

Best oral and poster presentation award are cancelled.

Topics

1 Asthma (Adult)
  • a: Mechanisms
  • b: Diangosis / Epidemiology
  • c: Treament / Management
2 Pediatric Asthma
3 Adult Airway Diseases
4 Atopic Dermatitis
5 Other Skin Diseases
6 Pollinosis
7 Rhinosinusitis
8 Ocular Allergy
9 Immunotherapy
10 Biologics
11 Food Allergy
  • a: Mechanisms
  • b: Diagnosis / Epidemiology
  • c: Treatment / Management
  • d: Non-lgE Food Allergy
  • e: Food Allergy in Adulthood
12 Eosinophilic Gastrointesinal Disease (EGID)
13 Drug Hypersensitivity
14 Anaphylaxis
15 Allergy Prevention and Risk Factors
16 Immunodeficiency and Collagen Disease
17 Mechanisms of Allergy
18 Animal Models
19 Microbiome and Omics
20 Air Pollution and Environmental Allergies
21 Education and Allied Health
22 Miscellaneous
23 Case Report

Abstract Submission Guideline

  1. Abstracts must be written in English.
  2. The maximum length allowed for an abstract is 400 words including authors' information.
    The abstract title: maximum of 25 words
    The abstract text: maximum of 330 words
  3. You are allowed to be the presenting author of multiple abstracts.
  4. No encore abstracts are accepted.

The abstract title

All abstract titles must be in lower case with no full stop (or period) at the end and no underlining.
Please see example below.

Example

○　Treatment of food allergy in Japan
×　TREATMENT OF FOOD ALLERGY in JAPAN.

The abstract text

Your abstract should be organized as such: Background, Method, Results, and Conclusion.

Example

  • A) Background: A statement of purpose of the study (preferably one sentence).
  • B) Methods: A brief statement of the methods used. For abstracts reporting clinical research, a sentence or phrase presenting the most important selection criteria for subjects should be included.
  • C) Results: A summary of the results presented in sufficient detail with statistical analysis to support the conclusions.
  • D) Conclusion: A statement of the conclusions reached.
    It is not satisfactory to state, "the results will be discussed," or "other data will be presented," etc.

Please note!
Abstracts must be proofread carefully to avoid errors before submission.

Affiliations

Example

  1. University, City, State, USA
  2. University, City, UK
  3. Hospital, Prefecture, Japan
  4. Company, Prefecture, Japan

Please note!
If affiliations are not listed as above, they will be modified by congress organizer in order to be included in Japanese Journal of Allergology.

  • Tables and graphs should not be included in the abstract.
  • References can be included in the body of the text.

Conflict-of-Interest Disclosure Policy

Main speaker is asked to show COI status in the first slide or the next slide after introducing presentation title and presenter, or display COI status at the end of poster.

Abstract Revisions

Changes to abstracts are accepted up to the submission deadline by using the abstract submission system.

Notification of Acceptance

Notification of acceptance/rejection will be sent to your e-mail address by the end of July, 2020.
The presenting author will receive all correspondence regarding the abstract status, presentation type, date and time, via the email provided in the abstract submission.

Abstract Withdrawal

Once an abstract is accepted, a written request to withdraw must be submitted no later than August 10, 2020, to abs_jsawac2020@c-linkage.co.jp if the first author decides to withdraw the abstract for any reason.

Publication of Abstracts

Accepted Abstract Authors will have their abstract published in Japanese Journal of Allergology.

“We remind authors that all accepted abstracts will be checked for plagiarism.”

  • By accepting this term, the authors confirm they have obtained written, informed consent of patients (or parents of children and adolescents) to publish their cases.

Attendance of Presenters

We cannot guarantee that Presenting Authors who do not show up during the session will be accepted for abstract presentations at JSA and WAO future meetings.

Registration and Payment

The Presenting Author must register for JSA/WAO Joint Congress 2020 and pay the registration fee before August 15, 2020. Abstracts will be automatically withdrawn if the Presenting Author is not registered by this time.

Travel Grants

“Travel Grants” are cancelled in the JSA/WAO Joint Congress 2020.

Inquiry

Please send inquiries regarding abstract submission to abs_jsawac2020@c-linkage.co.jp.
Thank you.

Online Submission System